Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsis survival

Overview of attention for article published in Critical Care, September 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 16 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 31 Dimensions

Readers on

mendeley: 46 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 16 X posts from 16 X users, with an upper bound of 63,488 followers.

Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in #sepsis: high plasma levels as combined risk markers for sepsis survival @Crit_Care | #ECM https://t.co/ilhKXSlksy

24 Sep 2018

Reply Repost Favourite

Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in #sepsis: high plasma levels as combined risk markers for sepsis survival @Crit_Care | #ECM https://t.co/kv76w2Lctd

24 Sep 2018

Reply Repost Favourite

RT @Crit_Care: Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsi…

21 Sep 2018

Reply Repost Favourite

RT @Crit_Care: Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsi…

21 Sep 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 12 additional X posts.